I attended National Health IT Week in Washington DC. There were a number of seminars and meetings focused on the growth of health IT in the United States.
Medication names that look or sound similar are problematic because they can be easily confused with each other. Examples of look-alike, sound-alike (LASA) medication names include hydralazine-hydroxyzine, Keflex-Keppra, metronidazole-metformin, Zyprexa-Zyrtec and Actonel-Actos. At least one out of every 1,000 prescriptions in the United States is associated with a wrong-medication error, and name confusion is thought to be a key cause.
The problem: medical device information within information systems currently is unstructured, incomplete, and in many cases simply unavailable. Fortunately, we are on the precipice of eliminating these unfortunate if onlys.
Patient engagement is defined by the Center for Advancing Health as “actions individuals must take to obtain the greatest benefit from the health care services available to them.” Certainly, such engagement is essential when it comes to one of the most important patient actions of all: taking medications. After all, as a Yoruba proverb says: “Medicine left in the bottle can’t help.”
FDB recently interviewed Jay Crowley to get his expert perspective on the Unique Device Identification (UDI) system. This is the second of a two-part blog series where Crowley offers his thoughts on the evolution and future of this emerging identification system.
FDB recently interviewed Jay Crowley to get his expert perspective on the Unique Device Identification (UDI) system. This is the first of a two-part blog series where Crowley offers his thoughts on the evolution and future of this emerging identification system.
Be notified about new FDB Blog posts as they are published by submitting the information below. (If you are already an FDB Customer in North America, you are automatically receiving blog updates by email and do not need to sign up.)
Director, Editorial Services
Senior Director, Meducation
VP, USDM Life Sciences
Strategic Alliances Director
Director, Software Development
VP, Health Policy
Strategy and Innovation, CCI
Manager, Consumer Drug Info
Senior VP and Editorial Director
Associate Product Manager
Howell, MD, PhD
VP, Clinical Applications